Macquarie Group LTD Cerus Corp Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $1.18 Million - $2 Million	-343,124 Closed	0 $8,000
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $2,174 - $2,805	493 Added 0.14%	343,124 $1.82 Million
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $329,201 - $478,402	68,441 Added 24.96%	342,631 $1.88 Million
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $39,342 - $52,258	6,590 Added 2.46%	274,190 $1.87 Million
Q2 2021 Aug 13, 2021	BUY	$5.35 - $6.35 $130,213 - $154,552	24,339 Added 10.01%	267,600 $1.58 Million
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $430,521 - $596,514	75,796 Added 45.26%	243,261 $1.46 Million
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $135,660 - $221,190	-25,840 Reduced 13.37%	167,465 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$5.78 - $7.47 $140,471 - $181,543	24,303 Added 14.38%	193,305 $1.21 Million
Q2 2020 Aug 11, 2020	SELL	$4.5 - $7.02 $96,210 - $150,087	-21,380 Reduced 11.23%	169,002 $1.12 Million
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $157,809 - $301,873	-54,986 Reduced 22.41%	190,382 $885,000
Q4 2019 Feb 14, 2020	BUY	$3.84 - $4.86 $180,656 - $228,643	47,046 Added 23.72%	245,368 $1.04 Million
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $53,965 - $67,179	-11,104 Reduced 5.3%	198,322 $1.02 Million
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $145,479 - $212,896	32,257 Added 18.21%	209,426 $1.18 Million
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $66,104 - $87,755	-12,811 Reduced 6.74%	177,169 $1.1 Million
Q4 2018 Feb 15, 2019	BUY	$4.89 - $7.16 $226,490 - $331,629	46,317 Added 32.24%	189,980 $963,000
Q3 2018 Nov 15, 2018	SELL	$6.89 - $7.78 $266,367 - $300,774	-38,660 Reduced 21.2%	143,663 $1.04 Million
Q2 2018 Aug 14, 2018	BUY	$5.19 - $7.25 $12,580 - $17,574	2,424 Added 1.35%	182,323 $1.22 Million
Q1 2018 May 11, 2018	SELL	$3.56 - $5.74 $194,376 - $313,404	-54,600 Reduced 23.28%	179,899 $986,000
Q4 2017 Feb 15, 2018	BUY	$2.76 - $3.95 $10,499 - $15,025	3,804 Added 1.65%	234,499 $793,000
Q3 2017 Nov 08, 2017	BUY	$2.22 - $2.73 $512,142 - $629,797	230,695	230,695 $630,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

Baker Bros. Advisors LP New York, NY

19.5M
Shares

$35.1 Million
0.36% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

18.2M
Shares

$32.8 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$25 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$19.5 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.54M
Shares

$15.4 Million
0.01% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $319M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account